Hedge Funds Shooting for the Starz (STRZA)

Spin-off situations tend to be good investment opportunities, as smaller divisions of larger companies tend to be misunderstood and incorrectly valued initially. In addition, the divested company can better focus on its specific business, increasing returns for shareholders in the process. Initially, the spun-off stock may underperform, as investors who received the shares might not want to hold it; once this selling pressure is gone, however, the stock tends to outperform.

During the fourth quarter of 2013, many ‘hedgies’ increased their holdings in the Class A shares of Starz (NASDAQ:STRZA), including Murray Stahl of Horizon Asset Management (who owns 8.1 million shares and is the fourth largest shareholder), Jeffrey Gates of Gates Capital Management (3.8 million shares) and Steven Cohen of SAC Capital Advisors (1.6 million shares). Other investors bullish on the stock include Warren Buffett of Berkshire Hathaway (with 4.5 million shares, the fifth largest shareholder), David Shaw of D E Shaw (890,000 shares) and Mario Gabelli of GAMCO Investors (763,000 shares).

Starz (NASDAQ:STRZA) is a $3.6 billion market cap integrated global media and entertainment company with operating units that provide premium subscription video programming on domestic U.S. pay television channels (Starz Networks), global content distribution (Starz Distribution) and animated television and movie production (Starz Animation). Liberty Media Corp (NASDAQ:LMCA) spun-off Starz in January 2013 at $14 per share to better focus on its investments in other companies, including Barnes&Noble Inc. (NYSE:BKS), Live Nation Entertainment (NYSE:LYV) and Sirius XM Radio Inc. (NASDAQ:SIRI).

Since then, the stock has been a strong performer, more than doubling following its divestiture. Despite rising costs for television content amid intense competition from both traditional cable networks like HBO, owned by Time Warner Inc. (NYSE:TWX), and alternative competitors such as Netflix Inc. (NASDAQ:NFLX), Starz (NASDAQ:STRZA) has generated strong earnings, aided by prudent expense management and growth in subscribers, who are increasingly interested in its original programming. In addition, following its spin-off, there had been heightened speculation that Starz was looking to sell itself to a larger buyer with multiple cable networks that could better leverage Starz’s growing original content, although that chatter seems to have died down recently.

Relative to its peer group of cable and satellite companies, Starz (NASDAQ:STRZA) looks favorable on most metrics, including above-average profit margins, high return on invested capital, strong free cash flow generation and manageable debt levels. The only negative comparison is the company’s EBITDA margin of 25%, which is below the peer group median of 30%. Valuation-wise, the stock trades at a discount to its peer group on a forward P/E basis (15.4X vs. 18.9X for peers) but a modest premium on a forward EV/EBITDA basis (10.0X vs. 8.3X for peers).

With a pipeline of original series, growing distribution in international markets and strong cash flows (approximately $475 million of which will be used to repurchase shares, equal to 13% of its market cap), Starz (NASDAQ:STRZA) is well-positioned to continue investing in its own content and grow its subscriber base while generating attractive returns for shareholders. At the same time, continued success as a stand-alone entity would make the stock a more attractive acquisition candidate by larger players.

Disclosure: none

Recommended Reading:

Hedge Funds Interested in Cole Real Estate Investments (COLE)

Christian Leone is Bullish on Lamar Advertising Co (LAMR) and Raises Stake to 5%

Tom Brown’s Second Curve Capital Raises Its Stake in Meta Financial Group Inc. (CASH)

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!